Prevalence of clinical isolates of Escherichia coli and Klebsiella spp. producing multiple extended-spectrum beta-lactamases.

@article{Romero2007PrevalenceOC,
  title={Prevalence of clinical isolates of Escherichia coli and Klebsiella spp. producing multiple extended-spectrum beta-lactamases.},
  author={Emilio David Valverde Romero and Trinidad Parras Padilla and Ana Hernandez and Rosa P{\'e}rez Grande and Marta V{\'a}zquez and Inmaculada Garc{\'i}a Garc{\'i}a and Jos{\'e} Angel Garc{\'i}a-Rodr{\'i}guez and Juan Luis Mu{\~n}oz Bellido},
  journal={Diagnostic microbiology and infectious disease},
  year={2007},
  volume={59 4},
  pages={433-7}
}
Eleven thousand two hundred seventy-two Escherichia coli, 1109 Klebsiella pneumoniae, 1124 Salmonella enterica, and 602 Klebsiella oxytoca unrelated clinical isolates were obtained between 2001 and 2004 in a university hospital in Salamanca, Spain. One hundred thirteen E. coli (1%), 32 K. pneumoniae (2.9%), 4 K. oxytoca (0.66%), and 5 S. enterica (0.44%) isolates produced extended-spectrum beta-lactamases (ESBLs). We obtained 42.2% of the ESBL-producing isolates from outpatients and 57.8% from… CONTINUE READING